281. I@W x RoundsTable - Brensocatib for Bronchiectasis and Alteplase for Posterior Circulation Ischemic Stroke
The Intern At Work: Internal Medicine
00:00
Trial design: inclusion, imaging, and outcomes
John outlines the open-label randomized design in China, alteplase dosing, PC-ASPECTS criterion, and primary mRS outcome at 90 days.
Play episode from 16:33
Transcript
